NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 08/28/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization61.89 mln
Float7.61 mln
Earnings Date10/08/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.6
Likely reliable
Relative Strength
95
/ 100
Top performer
Debt / Equity
0.46
Low leverage
Pre-Tax Margin
2%
Break-even
ROE
-8.75
Negative
Business Description
InterCure Ltd. is an Israeli company that grows, produces, and sells medical-grade cannabis and cannabis-based products to patients in Israel and abroad, offering both dried cannabis flower and oil-based extracts. The company also holds investments in the biomedical sector and works closely with Cannasoul R&D Ltd. to develop and bring to market cannabis treatments backed by clinical research. Founded in 1994 and based in Herzliya, Israel, InterCure operates across the full supply chain from cultivation to distribution.
